rivastigmine has been researched along with Ambulation Disorders, Neurologic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bamford, A; Ben-Shlomo, Y; Emmett, SR; Gaunt, DM; Henderson, EJ; Hollingworth, W; Metcalfe, C; Neumann, S; Steeds, D; Taylor, J; Whone, A | 1 |
| Ben-Shlomo, Y; Close, JC; Henderson, EJ; Lawrence, AD; Lord, SR; Whone, A | 1 |
| Balash, Y; Giladi, N; Gurevich, T; Hausdorff, JM; Herman, T; Merims, D; Peretz, C | 1 |
| Defebvre, L; Devos, D; Moreau, C | 1 |
| Ben-Shlomo, Y; Brodie, MA; Close, JC; Gaunt, DM; Henderson, EJ; Lawrence, AD; Lord, SR; Whone, AL | 1 |
| Amadori, K | 1 |
| Falkenburger, B | 1 |
| Barkhof, F; Lane, R; Scheltens, P; Staekenborg, SS; van der Flier, WM; van Straaten, EC | 1 |
6 trial(s) available for rivastigmine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.
Topics: Cholinesterase Inhibitors; Double-Blind Method; Gait Disorders, Neurologic; Humans; Parkinson Disease; Quality of Life; Rivastigmine | 2021 |
The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.
Topics: Accidental Falls; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Male; Parkinson Disease; Phenylcarbamates; Quality of Life; Rivastigmine; Statistics, Nonparametric; Treatment Outcome | 2013 |
Effect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Gait Disorders, Neurologic; Humans; Neuroprotective Agents; Phenylcarbamates; Pilot Projects; Rivastigmine | 2014 |
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.
Topics: Accidental Falls; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Rivastigmine | 2016 |
[Rivastigmine and Parkinson's disease without dementia : Impact on gait stability and frequency of falling].
Topics: Accidental Falls; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Double-Blind Method; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Placebo Effect; Rivastigmine; Treatment Outcome | 2016 |
Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Topics: Aged; Aged, 80 and over; Aphasia; Basal Ganglia Diseases; Brain Infarction; Cerebrovascular Circulation; Cholinesterase Inhibitors; Dementia, Vascular; Female; Gait Disorders, Neurologic; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Movement Disorders; Phenylcarbamates; Prevalence; Reflex, Abnormal; Rivastigmine; Thalamus | 2008 |
2 other study(ies) available for rivastigmine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Acetylcholinesterase inhibitors and gait: a steadying hand?
Topics: Cholinesterase Inhibitors; Female; Gait Disorders, Neurologic; Humans; Male; Outcome Assessment, Health Care; Parkinson Disease; Rivastigmine | 2016 |
ExPPNing how acetylcholine improves gait in Parkinson's disease: An Editorial Highlight for 'Deletion of the Vesicular Acetylcholine Transporter from Pedunculopontine/laterodorsal tegmental neurons modifies gait'.
Topics: Acetylcholine; Cholinergic Agents; Cholinesterase Inhibitors; Electric Stimulation; Gait Disorders, Neurologic; Humans; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Rivastigmine; Subthalamic Nucleus; Tegmentum Mesencephali; Vesicular Acetylcholine Transport Proteins | 2017 |